Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
Business Of Biotech - Podcast autorstwa Matt Pillar - Poniedziałki
Kategorie:
We love to hear from our listeners. Send us a message. Is it past time for a new approach to the COVID vaccine? Ocugen Chairman of the Board, Founder & CEO Shankar Musunuri, Ph.D. says yes, and his ideals would mark significant improvements: fewer shots, better durability, less post-vaccination transmission, and safety proven by time-tested technology. How would such a vaccine be produced? Dr. Musunuri lays out the manufacturing science— and why the improved COVID vaccine his company is c...
